326 related articles for article (PubMed ID: 19204190)
41. Curcumin Encapsulated into Biocompatible Co-Polymer PLGA Nanoparticle Enhanced Anti-Gastric Cancer and Anti-Helicobacter Pylori Effect.
Alam J; Dilnawaz F; Sahoo SK; Singh DV; Mukhopadhyay AK; Hussain T; Pati S
Asian Pac J Cancer Prev; 2022 Jan; 23(1):61-70. PubMed ID: 35092372
[TBL] [Abstract][Full Text] [Related]
42. In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation.
Srivastava AK; Tewari M; Shukla HS; Roy BK
Arch Pharm (Weinheim); 2015 Aug; 348(8):548-55. PubMed ID: 25996140
[TBL] [Abstract][Full Text] [Related]
43. In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pylori.
Gavrish E; Shrestha B; Chen C; Lister I; North EJ; Yang L; Lee RE; Han A; Williams B; Charnuska D; Coleman K; Lewis K; LaFleur MD
Antimicrob Agents Chemother; 2014 Jun; 58(6):3255-60. PubMed ID: 24687512
[TBL] [Abstract][Full Text] [Related]
44. Antimicrobial susceptibility profiles of Helicobacter pylori isolated from patients in North India.
Gehlot V; Mahant S; Mukhopadhyay AK; Das K; De R; Kar P; Das R
J Glob Antimicrob Resist; 2016 Jun; 5():51-6. PubMed ID: 27436467
[TBL] [Abstract][Full Text] [Related]
45. [Therapy of Helicobacter pylori infection: current status].
Wagner S; Gebel M; Manns M
Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
[TBL] [Abstract][Full Text] [Related]
46. A Mouse Model of Helicobacter pylori Infection.
Dey TK; Karmakar BC; Sarkar A; Paul S; Mukhopadhyay AK
Methods Mol Biol; 2021; 2283():131-151. PubMed ID: 33765316
[TBL] [Abstract][Full Text] [Related]
47. Antibiotic susceptibility of Helicobacter pylori isolates in Dakar, Senegal.
Seck A; Mbengue M; Gassama-Sow A; Diouf L; Ka MM; Boye CS
J Infect Dev Ctries; 2009 Sep; 3(2):137-40. PubMed ID: 19755744
[TBL] [Abstract][Full Text] [Related]
48. Helicobacter pylori in gastric biopsies of Taiwanese patients with gastroduodenal diseases.
Lin CW; Chang YS; Wu SC; Cheng KS
Jpn J Med Sci Biol; 1998 Nov; 51(1):13-23. PubMed ID: 10211428
[TBL] [Abstract][Full Text] [Related]
49. Promising in vitro and in vivo inhibition of multidrug-resistant Helicobacter pylori by linezolid and novel oxazolidinone analogues.
Shi J; Jiang Y; Zhao Y
J Glob Antimicrob Resist; 2016 Dec; 7():106-109. PubMed ID: 27718441
[TBL] [Abstract][Full Text] [Related]
50. Metformin can inhibit Helicobacter pylori growth.
Courtois S; Bénéjat L; Izotte J; Mégraud F; Varon C; Lehours P; Bessède E
Future Microbiol; 2018 Nov; 13():1575-1583. PubMed ID: 30421627
[TBL] [Abstract][Full Text] [Related]
51. In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori.
Filocamo A; Bisignano C; Ferlazzo N; Cirmi S; Mandalari G; Navarra M
BMC Complement Altern Med; 2015 Jul; 15():256. PubMed ID: 26220068
[TBL] [Abstract][Full Text] [Related]
52. Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.
Lee CW; Rickman B; Rogers AB; Ge Z; Wang TC; Fox JG
Cancer Res; 2008 May; 68(9):3540-8. PubMed ID: 18441088
[TBL] [Abstract][Full Text] [Related]
53. Antibacterial effects of the urushiol component in the sap of the lacquer tree (Rhus verniciflua Stokes) on Helicobacter pylori.
Suk KT; Baik SK; Kim HS; Park SM; Paeng KJ; Uh Y; Jang IH; Cho MY; Choi EH; Kim MJ; Ham YL
Helicobacter; 2011 Dec; 16(6):434-43. PubMed ID: 22059394
[TBL] [Abstract][Full Text] [Related]
54. Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat.
Pandya HB; Agravat HH; Patel JS; Sodagar NR
Indian J Med Microbiol; 2014; 32(4):408-13. PubMed ID: 25297026
[TBL] [Abstract][Full Text] [Related]
55. Management of Helicobacter pylori infections.
Abadi AT; Kusters JG
BMC Gastroenterol; 2016 Aug; 16(1):94. PubMed ID: 27520775
[TBL] [Abstract][Full Text] [Related]
56. Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates.
Kouitcheu Mabeku LB; Eyoum Bille B; Tepap Zemnou C; Tali Nguefack LD; Leundji H
BMC Infect Dis; 2019 Oct; 19(1):880. PubMed ID: 31640588
[TBL] [Abstract][Full Text] [Related]
57. Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults.
Lee JH; Shin JH; Roe IH; Sohn SG; Lee JH; Kang GH; Lee HK; Jeong BC; Lee SH
Antimicrob Agents Chemother; 2005 Apr; 49(4):1600-3. PubMed ID: 15793150
[TBL] [Abstract][Full Text] [Related]
58. The oligo-acyl lysyl antimicrobial peptide C₁₂K-2β₁₂ exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori.
Makobongo MO; Gancz H; Carpenter BM; McDaniel DP; Merrell DS
Antimicrob Agents Chemother; 2012 Jan; 56(1):378-90. PubMed ID: 22064541
[TBL] [Abstract][Full Text] [Related]
59. In vitro activity of Aloe vera inner gel against Helicobacter pylori strains.
Cellini L; Di Bartolomeo S; Di Campli E; Genovese S; Locatelli M; Di Giulio M
Lett Appl Microbiol; 2014 Jul; 59(1):43-8. PubMed ID: 24597562
[TBL] [Abstract][Full Text] [Related]
60. Anti-Helicobacter pylori activities of natural isopentenyloxycinnamyl derivatives from Boronia pinnata.
da Silva CR; Michel V; Genovese S; Prévost MC; Epifano F; Touati E
Nat Prod Commun; 2012 Oct; 7(10):1347-50. PubMed ID: 23157006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
